Diseases, Conditions, Syndromes

Guideline issued for nonsevere, severe COVID-19 therapy

(HealthDay)—In an evidence-based guideline developed by an international team of physicians, pharmacists, researchers, and patients, published online April 29 in CMAJ, the journal of the Canadian Medical Association, recommendations ...

Diseases, Conditions, Syndromes

In preparing for COVID-19 cases, plan early, communicate often

Hospitals facing a growing population of COVID-19 cases need a coordinated approach with a multidisciplinary team to increase efficiency, conserve PPE and protect staff. In "Hospital Preparedness for COVID-19: A Practical ...

Diseases, Conditions, Syndromes

Clinical trial for drug to treat severe COVID-19 patients

Yale researchers will begin a clinical trial at Yale-New Haven Hospital to test the effectiveness of a drug called ibudilast (MN-166) for treating acute respiratory distress syndrome (ARDS), a life-threatening lung condition ...

Diseases, Conditions, Syndromes

A bid to lower COVID-19 deaths

Acute Respiratory Distress Syndrome in patients with COVID-19 can lead to death but more than 50% of these cases are associated with co-infection with bacterial pathogens.

Diseases, Conditions, Syndromes

IDSA issues rapid guidelines for treatment of COVID-19

(HealthDay)—In rapid guidelines issued by the Infectious Diseases Society of America (IDSA), recommendations are presented for the treatment and management of coronavirus disease 2019 (COVID-19).

page 16 from 29